These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 20445192

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Hemolytic Uremic Syndrome in Pregnancy and Postpartum.
    Bruel A, Kavanagh D, Noris M, Delmas Y, Wong EKS, Bresin E, Provôt F, Brocklebank V, Mele C, Remuzzi G, Loirat C, Frémeaux-Bacchi V, Fakhouri F.
    Clin J Am Soc Nephrol; 2017 Aug 07; 12(8):1237-1247. PubMed ID: 28596415
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
    Albertazzi V, Bonucchi D, De Amicis S, Americo C, Ghiandai G, Cappelli G.
    Transplant Proc; 2010 May 07; 42(4):1352-4. PubMed ID: 20534299
    [Abstract] [Full Text] [Related]

  • 28. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
    Sevinc M, Basturk T, Sahutoglu T, Sakaci T, Koc Y, Ahbap E, Akgol C, Kara E, Brocklebank V, Goodship TH, Kavanagh D, Unsal A.
    J Med Case Rep; 2015 Apr 29; 9():92. PubMed ID: 25925370
    [Abstract] [Full Text] [Related]

  • 29. Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.
    Krid S, Roumenina LT, Beury D, Charbit M, Boyer O, Frémeaux-Bacchi V, Niaudet P.
    Am J Transplant; 2012 Jul 29; 12(7):1938-44. PubMed ID: 22494769
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Complement inhibitors are not useful in secondary hemolytic uremic syndromes.
    Duineveld C, Wetzels JFM.
    Kidney Int; 2019 Oct 29; 96(4):829-833. PubMed ID: 31543154
    [No Abstract] [Full Text] [Related]

  • 32. Recent advances in the management of atypical hemolytic uremic syndrome.
    Cataland SR.
    Clin Adv Hematol Oncol; 2012 Aug 29; 10(8):537-9. PubMed ID: 23073053
    [No Abstract] [Full Text] [Related]

  • 33. Drugs that inhibit complement.
    Schrezenmeier H, Höchsmann B.
    Transfus Apher Sci; 2012 Feb 29; 46(1):87-92. PubMed ID: 22169380
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Eculizumab in renal transplantation.
    Legendre C, Sberro-Soussan R, Zuber J, Rabant M, Loupy A, Timsit MO, Anglicheau D.
    Transplant Rev (Orlando); 2013 Jul 29; 27(3):90-2. PubMed ID: 23747093
    [Abstract] [Full Text] [Related]

  • 37. Eculizumab for congenital atypical hemolytic-uremic syndrome.
    Gruppo RA, Rother RP.
    N Engl J Med; 2009 Jan 29; 360(5):544-6. PubMed ID: 19179329
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Early initiation of eculizumab therapy for Streptococcus pneumoniae-associated hemolytic uremic syndrome.
    See J, Bou Matar R, Baloglu O, Latifi SQ, Talati R, Agarwal HS.
    Pediatr Blood Cancer; 2021 Feb 29; 68(2):e28589. PubMed ID: 32672848
    [No Abstract] [Full Text] [Related]

  • 40. Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab?
    Saland J.
    Pediatr Nephrol; 2014 Mar 29; 29(3):329-32. PubMed ID: 24362724
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.